UCB at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

UCB takes part in 2 sessions at Festival of Biologics 2026 in Basel. Its program covers new antibody formats and the use of AI agents in drug development. A highlight is how to put AI agents to work responsibly, looking at where they stand today and where they could go.

OrganizationFestival of Biologics 2026 Attendance
UCB
Brussels, Belgium
ucb.com
Large pharma
Global biopharmaceutical company developing medicines, including antibodies, for immunology and neurology.
Panel
Tue Oct 13
17:30
Panel Discussion: Next Generation Antibody Formats
Where antibody drug design is heading, from two-target antibodies and antibody-drug conjugates to AI's role in engineering them.
with Novartis, FairJourney Biologics, JJP Biologics
Talk
Wed Oct 14
17:50
Responsible AI Agents for drug development: Where we are, and what the future can be?
AI & Computational Approaches

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from UCB

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction